Post

How cell and gene therapy are evolving

The progress of advanced therapeutics in recent years, especially in oncology, have been so promising many are starting to use …

BIOSECURE “grandfather” amendment softens impact of US-China trade ban

An amendment to the US BIOSECURE bill will allow existing contracts with Chinese companies to be "grandfathered" in for eight …

AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs

The mid-year period marks a significant phase for horizon scanning activities that map the regulatory approval progress of innovative medicines …

EC grants orphan medicinal product status to Rocket’s RP-A601

The European Commission (EC) has granted orphan medicinal product designation for Rocket Pharmaceuticals’ RP-A601 gene therapy candidate to treat plakophilin-2 …

FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea

The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ AUSTEDO XR extended-release tablets as a once-daily treatment option …